MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.190 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
5 Biotech Stocks Under $5: Bionano Genomics, Northwest BioTherapeutics Plus 3 More Stocks
September 15, 2022 – TheNewswire - The biotechnology industry comprises hundreds of public companies that are fusing biology with technology to develop novel drugs and new products to advance the... 
Via TheNewswire.com
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
  
Via Benzinga
News headline image
7 Hot Growth Stocks Poised to Triple by 2030 ↗
For multiple reasons, this looks like a wonderful time for investors to buy hot growth stocks with very strong outlooks. 
Via InvestorPlace
News headline image
7 Cheap Penny Stocks to Buy Before They Boom ↗
If you have the stomach for extreme speculation, these cheap penny stocks to buy could move higher (but be ready for anything). 
Via InvestorPlace
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Recap: Bionano Genomics Q2 Earnings ↗
Bionano Genomics (NASDAQ:BNGO) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Bionano Genomic (BNGO) Stock Pops on Research Study ↗
Bionano Genomic is in the news today as a landmark research focusing on genomic mapping technology bolsters BNGO stock. 
Via InvestorPlace
News headline image
What In The World Is Going On With Bionano Genomics Shares? ↗
Bionano Genomics, Inc. (NASDAQ: BNGO) are trading higher by 11.8% to $3.36 Thursday afternoon. The company Thursday morning today announced the publication of the first study to evaluate the utility of... 
Via Benzinga
News headline image
Why Is Bionano Genomics (BNGO) Stock Up 20% Today? ↗
Bionano Genomics is in the news again, delivering groundbreaking nanoscale analytics research that has BNGO stock reaching for the stars. 
Via InvestorPlace
News headline image
Short Interest Sector Focus: Healthcare Sector ↗
As of the close of business on Thursday, 7/28, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
News headline image
The 7 Best Stocks to Buy on a Dip in July ↗
With the stock market pricing in a recession that likely won't arrive anytime soon, these are some of the best stocks to buy on a dip. 
Via InvestorPlace
News headline image
3 Stocks That Could Double in 2022 ↗
With the market shaking off its downturn and the economy strengthening, there are several stocks that could double before the year is out. 
Via InvestorPlace
News headline image
Hold On to Bionano Genomics Stock Until It Reaches $6 at Least ↗
After a year of blockbuster revenue growth, BNGO stock deserves a major re-rating 
Via InvestorPlace
News headline image
Earnings Scheduled For March 1, 2022 ↗
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
News headline image
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
News headline image
Looking Into Bionano Genomics's Return On Capital Employed ↗
Bionano Genomics (NASDAQ:BNGO) brought in sales totaling $5.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 30.52%, resulting in a loss of $29.95 million. 
Via Benzinga
News headline image
7 Cheap Biotech Stocks to Buy Now ↗
These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains. 
Via InvestorPlace
News headline image
Bionano Genomics's Earnings Outlook ↗
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Bionano... 
Via Benzinga
News headline image
The Latest Studies by Bionano Genomics Are Promising, But It’s Not a Buy Yet ↗
BNGO stock has provided positive news from study results lately, but its fundamentals are not great and not a reason to invest in it now. 
Via InvestorPlace
News headline image
Why Bionano Genomics Stock Is Risky, but a Good Bet ↗
The risks may be clear when it comes to Bionano Genomics and BNGO stock. However, investors should see this as a long-term play. 
Via InvestorPlace
News headline image
Bionano Genomics Stock Can Regain the Crucial $5 Level ↗
Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon. 
Via InvestorPlace
News headline image
Bionano Genomics May Finally Offer a Reward for Your Risk ↗
BNGO stock has been a falling knife for the past year. But, with promising fundamentals and good tailwinds, now be the time to take a chance. 
Via InvestorPlace
News headline image
Bionano Genomics's Return On Capital Employed Insights ↗
Benzinga Pro data, Bionano Genomics (NASDAQ:BNGO) reported Q4 sales of $6.30 million. Earnings fell to a loss of $22.95 million, resulting in a 10.58% decrease from last quarter... 
Via Benzinga
News headline image
Bionano Genomics's Earnings Outlook ↗
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
Bionano Genomics Has Attractive Applications But An Unattractive Stock Price ↗
BNGO stock will witness more hard times until profitability is improved and sales start to rebound. That could take some time. 
Via InvestorPlace
News headline image
Bionano Stock Looks to Have a Monster Comeback in Its Future ↗
Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly. 
Via InvestorPlace
News headline image
Investors Have Cast Their ‘No’ Votes Against Bionano Genomics ↗
A preliminary report from Bionano Genomics doesn't tell the full story and a lack of profitability will likely weigh on BNGO stock. 
Via InvestorPlace
News headline image
Bionano Is Not the Genomics Stock To Bet On ↗
Bionano's recent results are lackluster and point to more volatility ahead for BNGO stock. Best to just avoid this stock for now. 
Via InvestorPlace
News headline image
Bionano Genomics Is Interesting as Genome Testing Scales Upwards ↗
BNGO Stock is a play in the burgeoning gene sequencing market at scale, not at home. That's worth understanding and potentially purchasing. 
Via InvestorPlace
News headline image
Bionano Genomics Preliminary Q4, FY21 Revenue Exceed Expectations ↗
Bionano Genomics Inc (NASDAQ: BNGO) posted preliminary Q4 sales of $5.8 million - $6.2 million, +25% - 33% sequentially, up 45% - 55% Y/Y, and above the consensus... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story